{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:33:56Z","timestamp":1790746436731,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":829,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.exphem.2020.01.013","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T03:11:41Z","timestamp":1580353901000},"page":"57-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Clonal hematopoiesis in hematological disorders: Three different scenarios"],"prefix":"10.1016","volume":"83","author":[{"given":"Sabina","family":"Swierczek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef T.","family":"Prchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2020.01.013_bib0001","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM197610212951702","article-title":"Polycythemia vera: stem cell and probable clonal origin of the disease","volume":"295","author":"Adamson","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2020.01.013_bib0002","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/274590a0","article-title":"A common progenitor for human myeloid and lymphoid cells","volume":"274","author":"Prchal","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.01.013_bib0003","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-3-642-69722-7_13","article-title":"Tracing development and cell lineages in human hematopoietic neoplasia","volume":"30","author":"Fialkow","year":"1985","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2020.01.013_bib0004","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V58.5.916.916","article-title":"Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell","volume":"58","author":"Fialkow","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0005","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1073\/pnas.58.4.1468","article-title":"Clonal origin of chronic myelocytic leukemia in man","volume":"58","author":"Fialkow","year":"1967","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2020.01.013_bib0006","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood.V58.1.158.158","article-title":"Evidence for a multistep pathogenesis of chronic myelogenous leukemia","volume":"58","author":"Fialkow","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0007","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood.V85.1.21.bloodjournal85121","article-title":"Clonality in juvenile chronic myelogenous leukemia","volume":"85","author":"Busque","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0008","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/190372a0","article-title":"Gene action in the X-chromosome of the mouse (Mus musculus L.)","volume":"190","author":"Lyon","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.01.013_bib0009","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1073\/pnas.48.1.9","article-title":"The normal human female as a mosaic of X-chromosome activity: studies using the gene for C-6-PD-deficiency as a marker","volume":"48","author":"Beutler","year":"1962","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2020.01.013_bib0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.ge.17.120183.001103","article-title":"Mammalian X-chromosome inactivation","volume":"17","author":"Gartler","year":"1983","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.exphem.2020.01.013_bib0011","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0092-8674(92)90520-M","article-title":"The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus","volume":"71","author":"Brown","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2020.01.013_bib0012","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/379131a0","article-title":"Requirement of Xist in X chromosome inactivation","volume":"379","author":"Penny","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.01.013_bib0013","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/379116a0","article-title":"Pinpointing the center","volume":"379","author":"Lyon","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.01.013_bib0014","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.V88.1.59.59","article-title":"Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age","volume":"88","author":"Busque","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0015","first-page":"37","article-title":"Molecular and genetic studies of human X chromosome inactivation","volume":"2","author":"Brown","year":"1993","journal-title":"Adv Dev Biol"},{"key":"10.1016\/j.exphem.2020.01.013_bib0016","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2006-09-018655","article-title":"X-linked clonality testing: interpretation and limitations","volume":"110","author":"Chen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0017","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1056\/NEJM196702162760706","article-title":"Value of genetic variants of glucose-6-phosphate dehydrogenase in tracing the origin of malignant tumors","volume":"276","author":"Beutler","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2020.01.013_bib0018","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF02401419","article-title":"Polymorphisms in the coding and noncoding regions of murine Pgk-1 alleles","volume":"28","author":"Boer","year":"1990","journal-title":"Biochem Genet"},{"key":"10.1016\/j.exphem.2020.01.013_bib0019","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1073\/pnas.75.11.5631","article-title":"Polymorphism of DNA sequence adjacent to human \u03b2-globin structural gene: relationship to sickle mutation","volume":"75","author":"Kan","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2020.01.013_bib0020","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0140-6736(92)90653-K","article-title":"Studying X inactivation","volume":"339","author":"Curnutte","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2020.01.013_bib0021","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1182\/blood.V81.1.269.269","article-title":"Transcriptional analysis of the active X-chromosome in normal and clonal hematopoiesis","volume":"81","author":"Prchal","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0022","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1126\/science.2982210","article-title":"Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors","volume":"227","author":"Vogelstein","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.exphem.2020.01.013_bib0023","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJM198702193160802","article-title":"Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation","volume":"316","author":"Fearon","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2020.01.013_bib0024","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2141.1990.tb02601.x","article-title":"X-chromosome inactivation patterns using HPGRT and PGK polymorphisms in haematologically normal and post-chemotherapy females","volume":"74","author":"Abrahamson","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2020.01.013_bib0025","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1073\/pnas.88.15.6848","article-title":"Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction","volume":"88","author":"Gilliland","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2020.01.013_bib0026","first-page":"1229","article-title":"Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation","volume":"51","author":"Allen","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.exphem.2020.01.013_bib0027","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1182\/blood-2008-03-143925","article-title":"Hematopoiesis is not clonal in healthy elderly women","volume":"112","author":"Swierczek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0028","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1182\/blood-2011-11-390351","article-title":"Methylation of AR locus does not always reflect X chromosome inactivation state","volume":"119","author":"Swierczek","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0029","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/stem.5530110613","article-title":"A novel clonality assay based on transcriptional analysis of the active X chromosome","volume":"11","author":"Prchal","year":"1993","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2020.01.013_bib0030","first-page":"81","article-title":"A novel clonality assay based on transcriptional polymorphism of X chromosome gene p55","volume":"2","author":"Luhovy","year":"1995","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2020.01.013_bib0031","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V89.1.128","article-title":"Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T lymphocytes and platelets","volume":"89","author":"el-Kassar","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0032","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.183.2.561","article-title":"Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism","volume":"183","author":"Prchal","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2020.01.013_bib0033","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1172\/JCI119366","article-title":"Rapid determination of clonality by detection of two closely linked X chromosome exonic polymorphisms using allele-specific PCR","volume":"99","author":"Liu","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2020.01.013_bib0034","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0950-3536(98)80039-5","article-title":"Clonality markers in polycythaemia and primary thrombocythaemia","volume":"11","author":"Briere","year":"1998","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.exphem.2020.01.013_bib0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/(SICI)1096-8652(200004)63:4<184::AID-AJH4>3.0.CO;2-I","article-title":"A polymorphism of the X-linked gene IDS increases the number of females informative for transcriptional clonality assays","volume":"63","author":"Gregg","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2020.01.013_bib0036","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1038\/leu.2015.249","article-title":"Presence of polyclonal hematopoiesis in females with Ph-negative myeloproliferative neoplasms","volume":"12","author":"Swierczek","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2020.01.013_bib0037","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1073\/pnas.0601462103","article-title":"The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation","volume":"103","author":"Jamieson","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2020.01.013_bib0038","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood.V93.2.417","article-title":"Large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications","volume":"93","author":"Harrison","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0039","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.01.013_bib0040","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2020.01.013_bib0041","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"4","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2020.01.013_bib0042","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2020.01.013_bib0043","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0301-472X(01)00789-5","article-title":"Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera","volume":"3","author":"Kralovics","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2020.01.013_bib0044","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood-2005-11-009605","article-title":"Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders","volume":"108","author":"Kralovics","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0045","doi-asserted-by":"crossref","first-page":"32.e1","DOI":"10.1016\/j.exphem.2006.11.012","article-title":"Polycythemia vera is not initiated by JAK2V617F mutation","volume":"35","author":"Nussenzveig","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2020.01.013_bib0046","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"Greenman","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2020.01.013_bib0047","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1182\/blood-2009-01-197525","article-title":"Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms","volume":"118","author":"Saint-Martin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0048","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2009-09-245381","article-title":"Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms","volume":"115","author":"Schaub","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0049","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2020.01.013_bib0050","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/leu.2014.7","article-title":"Whole-exome sequencing of polycythemia vera revealed novel driver genes and somatic mutation shared by T cells and granulocytes","volume":"4","author":"Wang","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2020.01.013_bib0051","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1110557","article-title":"A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis","volume":"366","author":"Verstovsek","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2020.01.013_bib0052","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMoa1110556","article-title":"JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis","volume":"366","author":"Harrison","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2020.01.013_bib0053","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood-2013-02-485888","article-title":"Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis","volume":"122","author":"Cervantes","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0054","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3324\/haematol.2014.115840","article-title":"Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I","volume":"100","author":"Verstovsek","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2020.01.013_bib0055","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood-2015-03-635235","article-title":"The effect of long-term ruxolitinib treatment on JAK2p.V617F allele burden in patients with myelofibrosis","volume":"126","author":"Deininger","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-017-0417-z","article-title":"Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial","volume":"10","author":"Verstovsek","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.exphem.2020.01.013_bib0057","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1182\/blood-2002-07-2287","article-title":"Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin","volume":"101","author":"Liu","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0058","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2008-03-143537","article-title":"Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera","volume":"8","author":"Kiladjian","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0059","first-page":"1830","article-title":"Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses","volume":"8","author":"Tsewang","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2020.01.013_bib0060","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1182\/blood-2011-04-348144","article-title":"TNF\u03b1 facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms","volume":"24","author":"Fleischman","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0061","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.exphem.2015.05.013","article-title":"Comparative long-term effects of interferon alpha and hydroxyurea on human hematopoietic progenitor cells","volume":"43","author":"King","year":"2015","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2020.01.013_bib0062","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0090-1229(79)90067-9","article-title":"A study of a patient with chronic lymphocytic leukemia which demonstrates that proliferation of the lymphocytic clones in CLL does not include T-lymphocytes","volume":"13","author":"Prchal","year":"1979","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.exphem.2020.01.013_bib0063","series-title":"Williams Hematology","article-title":"Chronic lymphocytic leukemia","author":"Awan","year":"2015"},{"key":"10.1016\/j.exphem.2020.01.013_bib0064","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1182\/bloodadvances.2018020222","article-title":"Clinical consequences of clonal hematopoiesis of indeterminate potential","volume":"2","author":"Steensma","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2020.01.013_bib0065","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.mayocp.2018.04.002","article-title":"Clinical implications of clonal hematopoiesis","volume":"93","author":"Steensma","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.exphem.2020.01.013_bib0066","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1182\/blood.2019001113","article-title":"Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population","volume":"134","author":"Cordua","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0067","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/bjh.12099","article-title":"Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population","volume":"160","author":"Nielsen","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2020.01.013_bib0068","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1538-7836.2007.02424.x","article-title":"Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders","volume":"5","author":"De Stefano","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.exphem.2020.01.013_bib0069","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajh.21627","article-title":"Is the JAK2V617F mutation detectable in healthy volunteers?","volume":"85","author":"Martinaud","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2020.01.013_bib0070","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3324\/haematol.2010.033191","article-title":"The JAK2 V617F somatic mutation, mortality and cancer risk in the general population","volume":"96","author":"Nielsen","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2020.01.013_bib0071","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood-2006-03-009472","article-title":"JAK2(V617F): prevalence in a large Chinese hospital population","volume":"109","author":"Xu","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0072","first-page":"258","article-title":"Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms","volume":"4","author":"Anger","year":"1990","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2020.01.013_bib0073","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1182\/blood.V63.6.1318.1318","article-title":"Evidence for a multistep pathogenesis of a myelodysplastic syndrome","volume":"63","author":"Raskind","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0074","first-page":"659","article-title":"Probable clonal origin of acute myeloblastic leukemia following radiation and chemotherapy of colon cancer","volume":"52","author":"Wiggans","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0075","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2020.01.013_bib0076","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2020.01.013_bib0077","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0078","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","article-title":"Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly","volume":"130","author":"Zink","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2020.01.013_bib0079","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1253\/circj.CJ-18-0871","article-title":"Clonal hematopoiesis and its impact on cardiovascular disease","volume":"83","author":"Sano","year":"2018","journal-title":"Circ J"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X20300345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X20300345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:35:03Z","timestamp":1759566903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X20300345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":79,"alternative-id":["S0301472X20300345"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2020.01.013","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonal hematopoiesis in hematological disorders: Three different scenarios","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2020.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}